A fixed-dose randomized controlled trial of olanzapine for psychosis in Parkinson disease [v1; ref status: indexed, http://f1000r.es/1au]

A fixed-dose randomized controlled trial of olanzapine for psychosis in Parkinson disease [v1; ref status: indexed, http://f1000r.es/1au]

Background: Psychosis is a common and debilitating side effect of long-term dopaminergic treatment of Parkinson disease (PD). While clozapine is an effective treatment, the need for blood monitoring has limited its first-line use.  Objective: Since olanzapine shows similar receptor affinity to cloza...

Full description

Bibliographic Details
Main Authors: Michelle J Nichols, Johanna M Hartlein, Meredith GA Eicken, Brad A Racette, Kevin J Black
Format: Article
Language:English
Published: F1000 Research Ltd 2013-07-01
Series:F1000Research
Subjects:
Movement Disorders
Schizophrenia & Other Psychoses
Online Access:http://f1000research.com/articles/2-150/v1

Internet

http://f1000research.com/articles/2-150/v1

Similar Items